Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
ALLO Allogene Therapeutics
- 1.870
- +0.030+1.63%
Close Dec 20 16:00 ET
- 1.900
- +0.030+1.60%
Post 17:42 ET
392.09MMarket Cap-1.21P/E (TTM)
1.930High1.780Low4.99MVolume1.790Open1.840Pre Close9.34MTurnover3.29%Turnover RatioLossP/E (Static)209.67MShares5.77552wk High0.85P/B284.03MFloat Cap1.78052wk Low--Dividend TTM151.89MShs Float55.000Historical High--Div YieldTTM8.15%Amplitude1.780Historical Low1.870Avg Price1Lot Size
Allogene Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.56%-44.12M | -2.80%-63.59M | 16.12%-55.9M | -7.81%-237.73M | 13.51%-53.71M | -16.53%-55.53M | -45.44%-61.86M | 2.34%-66.64M | -19.32%-220.52M | -36.67%-62.1M |
| Net income from continuing operations | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M | -86.99%-340.41M | -119,436.05%-102.63M |
| Operating gains losses | -54.57%1.13M | -115.40%-375K | -68.35%929K | -17.16%10.67M | -68.56%2.81M | 51.27%2.5M | 263.31%2.44M | -22.76%2.94M | 214.99%12.88M | 283.99%8.92M |
| Depreciation and amortization | -10.22%3.21M | 0.03%3.64M | 1.37%3.56M | -0.67%14.2M | 13.33%3.48M | -7.46%3.57M | -0.87%3.64M | -5.01%3.51M | 36.74%14.3M | -27.68%3.07M |
| Other non cash items | -6.07%4.3M | -170.59%-96K | -136.90%-69K | -75.14%579K | -3,277.21%-4.32M | 727.67%4.58M | -88.42%136K | -59.87%187K | 103.18%2.33M | 100.18%136K |
| Change In working capital | 54.00%-8.88M | -284.26%-16.75M | -159.84%-4.44M | -492.74%-15.31M | -91.55%930K | -347.82%-19.3M | -185.49%-4.36M | 137.12%7.42M | 112.20%3.9M | 33,242.42%11M |
| -Change in prepaid assets | -115.57%-341K | -1,930.39%-1.87M | -106.81%-86K | -56.85%1.09M | -146.34%-2.47M | -61.61%2.19M | 105.54%102K | 118.93%1.26M | -21.32%2.52M | -0.45%5.33M |
| -Change in payables and accrued expense | 71.83%-4.7M | 233.39%5.83M | -186.13%-5.81M | -316.44%-14.32M | -100.21%-13K | -663.81%-16.68M | -161.22%-4.37M | 170.59%6.74M | 129.36%6.62M | 226.25%6.08M |
| -Change in other current assets | 501.37%1.47M | 777.00%677K | 3,111.11%1.45M | 56.36%-1.46M | -740.65%-1.03M | 10.29%-366K | -132.15%-100K | 101.45%45K | -416.10%-3.33M | -135.65%-123K |
| -Change in other current liabilities | 1,816.67%115K | 720.00%41K | 101.28%8K | 67.53%-611K | -98.10%4K | 101.15%6K | 100.53%5K | 1.42%-626K | -306.81%-1.88M | 117.77%210K |
| -Change in other working capital | ---5.42M | ---- | ---- | 85.71%-3K | 1,012.11%4.44M | ---- | ---- | 82.35%-3K | 99.95%-21K | -247.58%-487K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.56%-44.12M | -2.80%-63.59M | 16.12%-55.9M | -7.81%-237.73M | 13.51%-53.71M | -16.53%-55.53M | -45.44%-61.86M | 2.34%-66.64M | -19.32%-220.52M | -36.67%-62.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -121.76%-75.99M | 334.81%74.61M | -80.40%22.13M | 53.82%163.29M | 36.02%67.46M | -237.59%-34.27M | -68.24%17.16M | 604.69%112.94M | -35.13%106.16M | 69.56%49.6M |
| Net PPE purchase and sale | -3,475.00%-429K | --0 | 99.23%-8K | 70.80%-1.52M | 89.30%-181K | 94.62%-12K | 79.04%-288K | 45.58%-1.04M | 75.80%-5.19M | -129.89%-1.69M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | -120.59%-75.56M | 327.63%74.61M | -80.57%22.14M | 48.01%164.81M | 31.88%67.64M | -236.32%-34.26M | -68.51%17.45M | 656.63%113.97M | -45.10%111.35M | 61.50%51.29M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -121.76%-75.99M | 334.81%74.61M | -80.40%22.13M | 53.82%163.29M | 36.02%67.46M | -237.59%-34.27M | -68.24%17.16M | 604.69%112.94M | -35.13%106.16M | 69.56%49.6M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -84.15%679K | 21.31%108.6M | -4.68%1.65M | 3,143.90%95.7M | 236.96%155K | 301.97%4.29M | 372,916.67%89.52M | -4.58%1.73M | -75.34%2.95M | -85.71%46K |
| Net common stock issuance | --0 | ---- | ---- | --91.11M | --0 | --3.19M | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | -37.76%679K | -98.82%19K | -4.68%1.65M | 55.36%4.58M | 236.96%155K | 2.35%1.09M | 6,591.67%1.61M | -4.58%1.73M | -75.34%2.95M | -85.71%46K |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -84.15%679K | 21.31%108.6M | -4.68%1.65M | 3,143.90%95.7M | 236.96%155K | 301.97%4.29M | 372,916.67%89.52M | -4.58%1.73M | -75.34%2.95M | -85.71%46K |
| Net cash flow | ||||||||||
| Beginning cash position | 9.64%180.96M | -48.99%61.33M | 29.44%93.45M | -60.68%72.2M | -6.04%79.54M | 55.22%165.05M | 26.81%120.22M | -60.68%72.2M | -4.77%183.61M | -57.56%84.65M |
| Current changes in cash | -39.66%-119.43M | 166.87%119.63M | -166.87%-32.12M | 119.07%21.25M | 211.69%13.91M | -294.36%-85.51M | 288.89%44.83M | 154.08%48.03M | -1,111.77%-111.41M | 21.50%-12.45M |
| End cash Position | -22.64%61.53M | 9.64%180.96M | -48.99%61.33M | 29.44%93.45M | 29.44%93.45M | -6.04%79.54M | 55.22%165.05M | 26.81%120.22M | -60.68%72.2M | -60.68%72.2M |
| Free cash flow | 19.80%-44.54M | -2.32%-63.59M | 17.39%-55.91M | -6.00%-239.25M | 15.52%-53.89M | -16.01%-55.54M | -41.54%-62.15M | 3.51%-67.67M | -9.43%-225.71M | -38.15%-63.79M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.